| Year |
Citation |
Score |
| 2023 |
Kaiser AM, Gatto A, Hanson KJ, Zhao RL, Raj N, Ozawa MG, Seoane JA, Bieging-Rolett KT, Wang M, Li I, Trope WL, Liou DZ, Shrager JB, Plevritis SK, Newman AM, et al. p53 governs an AT1 differentiation programme in lung cancer suppression. Nature. PMID 37468633 DOI: 10.1038/s41586-023-06253-8 |
0.4 |
|
| 2022 |
Raj N, Wang M, Seoane JA, Zhao RL, Kaiser AM, Moonie NA, Demeter J, Boutelle AM, Kerr CH, Mulligan AS, Moffatt C, Zeng SX, Lu H, Barna M, Curtis C, et al. The Mettl3 epitranscriptomic writer amplifies p53 stress responses. Molecular Cell. PMID 35512709 DOI: 10.1016/j.molcel.2022.04.010 |
0.505 |
|
| 2021 |
Tiu GC, Kerr CH, Forester CM, Krishnarao PS, Rosenblatt HD, Raj N, Lantz TC, Zhulyn O, Bowen ME, Shokat L, Attardi LD, Ruggero D, Barna M. A p53-dependent translational program directs tissue-selective phenotypes in a model of ribosomopathies. Developmental Cell. PMID 34242585 DOI: 10.1016/j.devcel.2021.06.013 |
0.408 |
|
| 2020 |
Valente LJ, Tarangelo A, Li AM, Naciri M, Raj N, Boutelle AM, Li Y, Mello SS, Bieging-Rolett K, DeBerardinis RJ, Ye J, Dixon SJ, Attardi LD. p53 deficiency triggers dysregulation of diverse cellular processes in physiological oxygen. The Journal of Cell Biology. 219. PMID 32886745 DOI: 10.1083/Jcb.201908212 |
0.516 |
|
| 2019 |
Raj N, Bam R. Reciprocal Crosstalk Between YAP1/Hippo Pathway and the p53 Family Proteins: Mechanisms and Outcomes in Cancer. Frontiers in Cell and Developmental Biology. 7: 159. PMID 31448276 DOI: 10.3389/Fcell.2019.00159 |
0.519 |
|
| 2018 |
Mello SS, Bieging-Rolett K, Kaiser A, Valente EJ, Raj N, McClendon J, Flowers BM, Morgens DW, Bassik MC, Attardi LD. Abstract IA07: Deconstructing p53 pathways in tumor suppression Cancer Research. 78. DOI: 10.1158/1538-7445.Mousemodels17-Ia07 |
0.542 |
|
| 2017 |
Mello SS, Valente LJ, Raj N, Seoane JA, Flowers BM, McClendon J, Bieging-Rolett KT, Lee J, Ivanochko D, Kozak MM, Chang DT, Longacre TA, Koong AC, Arrowsmith CH, Kim SK, et al. A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer. Cancer Cell. 32: 460-473.e6. PMID 29017057 DOI: 10.1016/J.Ccell.2017.09.007 |
0.508 |
|
| 2017 |
Mello SS, Sinow C, Raj N, Mazur PK, Bieging-Rolett K, Broz DK, Imam JFC, Vogel H, Wood LD, Sage J, Hirose T, Nakagawa S, Rinn J, Attardi LD. Neat1 is a p53-inducible lincRNA essential for transformation suppression. Genes & Development. PMID 28698299 DOI: 10.1101/Gad.284661.116 |
0.529 |
|
| 2016 |
Raj N, Attardi LD. The Transactivation Domains of the p53 Protein. Cold Spring Harbor Perspectives in Medicine. PMID 27864306 DOI: 10.1101/Cshperspect.A026047 |
0.519 |
|
| 2016 |
Attardi LD, Mello SS, Valente EJ, Mazur PK, Raj N, Bieging-Rolett K, Vogel H. Abstract PR07: Deconstructing p53 transcriptional networks in pancreatic cancer suppression Cancer Research. 76. DOI: 10.1158/1538-7445.Panca16-Pr07 |
0.39 |
|
| 2013 |
Raj N, Attardi LD. Tumor suppression: P53 alters immune surveillance to restrain liver cancer Current Biology. 23: R527-R530. PMID 23787049 DOI: 10.1016/J.Cub.2013.04.076 |
0.449 |
|
| 2012 |
Raj N, Zhang L, Wei Y, Arnosti DN, Henry RW. Ubiquitination of retinoblastoma family protein 1 potentiates gene-specific repression function. The Journal of Biological Chemistry. 287: 41835-43. PMID 23086928 DOI: 10.1074/Jbc.M112.422428 |
0.541 |
|
| 2012 |
Raj N, Zhang L, Wei Y, Arnosti DN, Henry RW. Rbf1 degron dysfunction enhances cellular DNA replication. Cell Cycle (Georgetown, Tex.). 11: 3731-8. PMID 22895052 DOI: 10.4161/Cc.21665 |
0.56 |
|
| 2010 |
Acharya P, Raj N, Buckley MS, Zhang L, Duperon S, Williams G, Henry RW, Arnosti DN. Paradoxical instability-activity relationship defines a novel regulatory pathway for retinoblastoma proteins. Molecular Biology of the Cell. 21: 3890-901. PMID 20861300 DOI: 10.1091/Mbc.E10-06-0520 |
0.538 |
|
| Show low-probability matches. |